Soleus Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Soleus Capital Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-54,089	Closed	-$2.76M	–	81
2020 Q3	$2.76M	Buy	54,089 +5,289	+11%	+$221K	1.46%	29
2020 Q2	$1.71M	Sell	48,800 -14,200	-23%	-$489K	0.98%	31
2020 Q1	$1.6M	Buy	+63,000	New	+$1.87M	1.86%	19

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Soleus Capital Management's AXNX Position: Q4 2020 in Review

Soleus Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2020, closing a stake of 54,089 shares — an estimated $2.76M sold.

Soleus Capital Management first reported a position in AXNX in Q1 2020 and held it in 3 quarters. The position peaked at $2.76M in Q3 2020. 149 funds tracked by Wall St. Rank hold AXNX as of Q4 2020.

Soleus Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Soleus Capital Management sold 54,089 Axonics, Inc. Common Stock shares in Q4 2020, an estimated $2.76M.
Soleus Capital Management first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
Soleus Capital Management's Axonics, Inc. Common Stock position peaked at $2.76M in Q3 2020.
149 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2020.

Based on Soleus Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.